Product Description: Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]McBride JM, et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum. 2012 Nov;64(11):3666-76.
CAS Number: 948570-30-7
Molecular Weight: 145.9 (kDa)
Compound Purity: 96.87
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Others